Both are clinically equivalent when sourced from licensed compounding facilities meeting FDA standards
Peptide therapy for adults over 60 is clinically viable and increasingly relevant
This fact further raises the possibility of practical applications targeting IGF-1R
Meta-analyses and randomized controlled trials consistently show that self-monitoring of weight, diet, and activity predicts greater weight loss, and that more frequent feedback strengthens the monitoring habit, which then drives outcomes
On December 15, 2025, the Judicial Panel on Multidistrict Litigation centralized lawsuits alleging vision loss from GLP-1 drugs, like Ozempic
Common initial side effects include nausea, diarrhea, and decreased appetite most of which improve within the first 48 weeks